StockData

Core Scientific vs Riot Platforms

CORZ and RIOT side by side, both in finance services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How CORZ and RIOT compare

Riot Platforms is the larger company, worth 1.4 times as much as Core Scientific ($6.6B against $4.7B).

Core Scientific grew revenue faster over the last twelve months (77.2% versus 6.1% for Riot Platforms).

Core Scientific keeps more of each dollar of sales as profit, with a net margin of −18.3% compared with −211% at Riot Platforms.

Core Scientific scores higher on the StockData Score (4 against 3 for Riot Platforms), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricCORZRIOT
Size and price
Market cap$4.7B$6.6B
Share price$14.52$17.52
Change, 1 year−11.7%13.3%
Change, 5 years–−51.6%
Beta (5Y)–2.78
Employees325816
StockData Score
Total score4 (better)3
Valuation score00
Growth score2 (better)1
Performance score2 (better)0
Health score02 (better)
Dividend score00
Valuation
P/S7.9× (better)9.7×
P/B–3.1×
FCF yield−28.3%−13.7% (better)
Fair value$4.93$8.44
Margin of safety−194%−108% (better)
Growth
Revenue growth (TTM)77.2% (better)6.1%
Revenue growth, 5Y average39.5%122% (better)
Net income growth (TTM)–−969%
Profitability
Gross margin41.2%–
Operating margin−73.3% (better)−211%
Net margin−18.3% (better)−211%
FCF margin−223%−133% (better)
Return on equity–−50.5%
Return on invested capital−39.0%−36.6% (better)
Financial health
Debt / equity–0.31
Current ratio0.673.49 (better)
Altman Z-score−0.942.35 (better)
Piotroski F-score4 (better)1
Dividends and buybacks
Buyback yield–1.3%
Shareholder yield0.00%1.3% (better)
Ownership
Held by institutions136%84.1%
Held by insiders11.7%6.6%
Insider net buying, 12 months−$6.2M (better)−$9.5M
Superinvestors holding34 (better)
Short interest, % of float–15.2%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.